Bastide : Q2 sales in line and impacted by price effects – guidance reiterated – estimates unchanged
>Q2 quite in line although organic growth has slowed down - Q2 sales came in at € 91.3m, i.e. +7.2% and +5.2% at constant scope.At end-December, sales totaled € 176.6m, spread between MAD (€ 82.9m, +7.7%), PNI (€ 45.6m, +9.1%) and ARD (€ 48.1m, +7.9%). Bastide reiterated its guidance: sales of between € 355m and € 365me, i.e. +5.8/+8.9%e and an underlying operating margin of between 8.5% and 9% (Oddo: 8.6% estimated).As usual, Bastide specified that it...Bastide le Confort Medical is a holding company. Through its subsidiaries, Co. is engaged in the home health care industry. Co. retails and rents medical equipment and provides medical services. Products include breathing apparatus, orthopedic shoes, walking aids and wheelchairs, home appliances and furniture adapted to the needs of the lesser able, with the recent addition of equipment related to perfusion and nutrition. Co. operates through a number of outlets concentrated mainly in the South of France, offering advice and information to customers along with the provision and maintenance of medical equipment.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.